Rachelle R. Sowell

Next Post

OncoSec Medical (NASDAQ:ONCS) Now Covered by Analysts at StockNews.com

Thu Apr 14 , 2022
StockNews.com initiated coverage on shares of OncoSec Professional medical (NASDAQ:ONCS – Get Score) in a report released on Monday. The brokerage set a “sell” score on the biotechnology company’s inventory. Separately, BTIG Investigate minimized their concentrate on cost on OncoSec Clinical from $10.00 to $5.00 and established a “buy” rating […]